# A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fed Condition

> **NCT01079052** · NA · COMPLETED · sponsor: **Ranbaxy Laboratories Limited** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Famotidine

## Key facts

- **NCT ID:** NCT01079052
- **Lead sponsor:** Ranbaxy Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2007-11
- **Final completion:** 2007-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2010-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01079052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01079052, "A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fed Condition". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01079052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*